Rapamycin selectively inhibits expression of an inducible keratin (K6a) in human keratinocytes and improves symptoms in pachyonychia congenita patients
- 1 November 2009
- journal article
- Published by Elsevier BV in Journal of Dermatological Science
- Vol. 56 (2), 82-88
- https://doi.org/10.1016/j.jdermsci.2009.07.008
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- Targeting the mTOR Signaling Network for Cancer TherapyJournal of Clinical Oncology, 2009
- Therapeutic siRNAs for dominant genetic skin disorders including pachyonychia congenitaJournal of Dermatological Science, 2008
- Comprehensive detection of human terminal oligo-pyrimidine (TOP) genes and analysis of their characteristicsNucleic Acids Research, 2008
- Local Translation in Primary Afferent Fibers Regulates NociceptionPLOS ONE, 2008
- The Splicing Factor SF2/ASF Regulates Translation Initiation by Enhancing Phosphorylation of 4E-BP1Molecular Cell, 2008
- TemsirolimusDrugs, 2008
- Role of the highly structured 5′-end region of MDR1 mRNA in P-glycoprotein expressionBiochemical Journal, 2007
- Pathological angiogenesis is induced by sustained Akt signaling and inhibited by rapamycinCancer Cell, 2006
- EverolimusDrugs, 2006
- Evidence for posttranscriptional regulation of the keratins expressed during hyperproliferation and malignant transformation in human epidermis.The Journal of cell biology, 1986